Standardization of the tumor-stroma ratio scoring method for breast cancer research
Authors:
Open Access
- 16 April 2022
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 193 (3) , 545-553
Abstract
Purpose: The tumor-stroma ratio (TSR) has repeatedly proven to be correlated with patient outcomes in breast cancer using large retrospective cohorts. However, studies validating the TSR often show variability in methodology, thereby hampering comparisons and uniform outcomes. Method: This paper provides a detailed description of a simple and uniform TSR scoring method using Hematoxylin and Eosin (H&E)-stained core biopsies and resection tissue, specifically focused on breast cancer. Possible histological challenges that can be encountered during scoring including suggestions to overcome them are reported. Moreover, the procedure for TSR estimation in lymph nodes, scoring on digital images and the automatic assessment of the TSR using artificial intelligence are described. Conclusion: Digitized scoring of tumor biopsies and resection material offers interesting future perspectives to determine patient prognosis and response to therapy. The fact that the TSR method is relatively easy, quick, and cheap, offers great potential for its implementation in routine diagnostics, but this requires high quality validation studies.Keywords
Funding Information
- Bollenstreekfonds, Lisse, The Netherlands
This publication has 49 references indexed in Scilit:
- The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trialAnnals of Oncology, 2012
- The prognostic value of tumour-stroma ratio in triple-negative breast cancerEuropean Journal of Surgical Oncology, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Reproducibility and validation of tumour stroma ratio scoring on oesophageal adenocarcinoma biopsiesEuropean Journal of Cancer, 2011
- Hallmarks of cancer: Interactions with the tumor stromaExperimental Cell Research, 2010
- The proportion of tumour cells is an independent predictor for survival in colorectal cancer patientsBritish Journal of Cancer, 2010
- Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patientsBreast Cancer Research and Treatment, 2010
- The stromal part of adenocarcinomas of the oesophagus: Does it conceal targets for therapy?European Journal of Cancer, 2010
- PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancerBreast Cancer Research, 2010
- Stromal Compartment as a Survival Prognostic Factor in Advanced Ovarian CarcinomaInternational Journal of Gynecological Cancer, 2010